Sigma Planning Corp boosted its stake in Clorox Company (The) (NYSE:CLX) by 7.4% in the third quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 23,221 shares of the company’s stock after purchasing an additional 1,599 shares during the period. Sigma Planning Corp’s holdings in Clorox Company (The) were worth $3,063,000 at the end of the most recent reporting period.
A number of other hedge funds and other institutional investors also recently bought and sold shares of the stock. Vanguard Group Inc. grew its holdings in Clorox Company (The) by 2.6% during the 2nd quarter. Vanguard Group Inc. now owns 14,534,634 shares of the company’s stock worth $1,936,595,000 after acquiring an additional 369,918 shares during the period. State Street Corp grew its holdings in Clorox Company (The) by 2.2% during the 1st quarter. State Street Corp now owns 7,648,999 shares of the company’s stock worth $1,031,304,000 after acquiring an additional 167,689 shares during the period. Parnassus Investments CA grew its holdings in Clorox Company (The) by 1.7% during the 3rd quarter. Parnassus Investments CA now owns 4,451,150 shares of the company’s stock worth $587,151,000 after acquiring an additional 76,236 shares during the period. Wells Fargo & Company MN grew its holdings in Clorox Company (The) by 5.3% during the 2nd quarter. Wells Fargo & Company MN now owns 4,412,600 shares of the company’s stock worth $587,934,000 after acquiring an additional 221,168 shares during the period. Finally, Valueinvest Asset Management S.A. grew its holdings in Clorox Company (The) by 6.9% during the 1st quarter. Valueinvest Asset Management S.A. now owns 1,580,400 shares of the company’s stock worth $213,085,000 after acquiring an additional 102,300 shares during the period. Institutional investors and hedge funds own 71.58% of the company’s stock.
Shares of Clorox Company (NYSE:CLX) traded down $0.08 during midday trading on Tuesday, reaching $135.01. 264,605 shares of the company traded hands, compared to its average volume of 817,432. Clorox Company has a twelve month low of $112.15 and a twelve month high of $141.76. The company has a market cap of $17,026.34, a PE ratio of 23.79, a price-to-earnings-growth ratio of 3.60 and a beta of 0.39. The company has a debt-to-equity ratio of 3.02, a quick ratio of 0.77 and a current ratio of 1.10.
Clorox Company (The) (NYSE:CLX) last posted its earnings results on Wednesday, November 1st. The company reported $1.46 EPS for the quarter, topping the Thomson Reuters’ consensus estimate of $1.41 by $0.05. Clorox Company (The) had a net margin of 11.84% and a return on equity of 161.59%. The firm had revenue of $1.50 billion for the quarter, compared to analysts’ expectations of $1.48 billion. During the same quarter last year, the firm earned $1.36 EPS. The company’s quarterly revenue was up 4.0% compared to the same quarter last year. equities analysts predict that Clorox Company will post 5.58 EPS for the current fiscal year.
The business also recently declared a quarterly dividend, which was paid on Monday, November 13th. Stockholders of record on Wednesday, October 25th were paid a dividend of $0.84 per share. The ex-dividend date was Tuesday, October 24th. This represents a $3.36 annualized dividend and a dividend yield of 2.49%. Clorox Company (The)’s payout ratio is currently 61.88%.
In other news, COO Dawn C. Willoughby sold 2,158 shares of the firm’s stock in a transaction that occurred on Tuesday, August 29th. The shares were sold at an average price of $138.00, for a total transaction of $297,804.00. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. Also, EVP James E. Foster sold 9,861 shares of the firm’s stock in a transaction that occurred on Wednesday, August 23rd. The stock was sold at an average price of $138.51, for a total transaction of $1,365,847.11. Following the sale, the executive vice president now owns 22,069 shares of the company’s stock, valued at approximately $3,056,777.19. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 41,293 shares of company stock valued at $5,560,303. 1.00% of the stock is currently owned by company insiders.
A number of analysts have weighed in on CLX shares. Deutsche Bank AG reiterated a “hold” rating and set a $137.00 price target (up from $126.00) on shares of Clorox Company (The) in a report on Saturday, July 22nd. BidaskClub downgraded Clorox Company (The) from a “sell” rating to a “strong sell” rating in a report on Monday, July 24th. Zacks Investment Research downgraded Clorox Company (The) from a “buy” rating to a “hold” rating in a report on Monday, July 31st. Royal Bank Of Canada reiterated a “hold” rating and set a $115.00 price target on shares of Clorox Company (The) in a report on Wednesday, August 2nd. Finally, BMO Capital Markets set a $150.00 price target on Clorox Company (The) and gave the stock a “buy” rating in a report on Thursday, August 3rd. Two research analysts have rated the stock with a sell rating, ten have assigned a hold rating and three have assigned a buy rating to the stock. The stock presently has an average rating of “Hold” and a consensus price target of $128.72.
COPYRIGHT VIOLATION NOTICE: This article was originally published by Transcript Daily and is the sole property of of Transcript Daily. If you are viewing this article on another domain, it was stolen and reposted in violation of international copyright and trademark laws. The original version of this article can be accessed at https://transcriptdaily.com/2017/11/14/sigma-planning-corp-buys-1599-shares-of-clorox-company-the-clx.html.
Clorox Company (The) Company Profile
The Clorox Company is a manufacturer and marketer of consumer and professional products. The Company sells its products primarily through mass retail outlets, e-commerce channels, wholesale distributors and medical supply distributors. The Company operates through four segments: Cleaning, Household, Lifestyle and International.
Receive News & Ratings for Clorox Company (The) Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox Company (The) and related companies with MarketBeat.com's FREE daily email newsletter.